- Home
- LBRX vs WRN Comparison
LBRX vs WRN Comparison
Compare LBRX & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBRX | WRN |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.6M | 676.9M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | LBRX | WRN |
|---|---|---|
| Price | $23.91 | $3.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $49.00 | $4.88 |
| AVG Volume (30 Days) | 181.2K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.40 | $0.90 |
| 52 Week High | $25.60 | $4.26 |
Technical Indicators
Market Signals| Indicator | LBRX | WRN |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 47.38 |
| Support Level | $22.34 | $2.95 |
| Resistance Level | $24.70 | $3.50 |
| Average True Range (ATR) | 1.26 | 0.20 |
| MACD | -0.14 | -0.04 |
| Stochastic Oscillator | 51.76 | 45.63 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).